All Type of News
Will multiple myeloma treatment meet a new paradigm?
As a number of products emerges – DDP-4 inhibitors, SGLT-2 inhibitors, basal insulin and GLP-1 agonists –, ‘diabetes treatment’ has met a new treatment paradigm. Emergence of various treatments has allowed patients to...
MFDS only to leave site inspection for ‘White List’
It was known the Ministry of Food and Drug Safety(MFDS) has only left the site inspection phase for the procedure of the ‘White List’ registration, also known as the PIC/s of active pharmaceutical ingredients.
Accord...
FDA begins approval procedure of the first antibody biosimilar, Celltrion’s ‘Remsima’
Through its website, the U.S. Food and Drug Administration(hereinafter referring to FDA) announced that it is expected to hold the Arthritis Advisory Committee at the FDA White Oak Campus in Maryland and discuss matte...
3 mega-blockbuster products recording annual KRW 1 trillion sales in pharmaceutical industry
It was estimated there will be the total 3 mega-blockbuster products exceeding annual KRW 100 billion sales in the pharmaceutical industry last year.
KRW 100 billion sales from a single product are as equivalent as a...
Golden age of domestic biopharmaceutical products, pouring foreign entries
At the beginning of the year, foreign expansion of domestic biopharmaceutical products has produced results. While technology of the anemia treatment being developed by Chong Kun Dang is exported, Samsung Bioepis acqu...
Dong-A ST creates antidiabetic agent combining ‘Suganon-Actos’Dong-A ST has started to develop a complex combining Suganon(evogliptin), a domestic DPP-4-inhibitor treatment, and Actos(pioglitazone, Takeda Pharmaceutical), a TZD-type drug.
...
|
Multinational pharmaceutical companies being ignored by domestic ones as ignoring ‘win-win’
There have been a number of issues about cooperation of domestic pharmaceutical companies with multinational pharmaceutical companies, such as ‘co-marketing’ and ‘co-promotion.’
As most pharmaceutical companies estab...
Pfizer wins the final nullification trial on the use patent of LyricaPfizer has won the final nullification trial filed by generic companies on the use patent of ‘Lyrica(generic name: pregabalin).’ The Supreme Court made a final ruling the use pa...
|
Pharmaceutical companies to rush founding new factories, “Targeting the global market”
Domestic pharmaceutical companies have actively started to invest funds on manufacturing facilities. The purpose of the investment is to secure capability to expand their products into the global market.
In fact, all...
Facing entry of follow-up drugs, Tamiflu to be launched in a new formation
‘Tamiflu,’ an antiviral drug which soon will face the entry of follow-up drugs due to the expiration of its substance patent, has attracted attention of the industry with different volume types.
According to the Mini...
